MX2015007131A - Ensayos rapidos de bajo volumen de muestra de colesterol y trigliceridos. - Google Patents

Ensayos rapidos de bajo volumen de muestra de colesterol y trigliceridos.

Info

Publication number
MX2015007131A
MX2015007131A MX2015007131A MX2015007131A MX2015007131A MX 2015007131 A MX2015007131 A MX 2015007131A MX 2015007131 A MX2015007131 A MX 2015007131A MX 2015007131 A MX2015007131 A MX 2015007131A MX 2015007131 A MX2015007131 A MX 2015007131A
Authority
MX
Mexico
Prior art keywords
cholesterol
assays
density lipoprotein
sub
fractions
Prior art date
Application number
MX2015007131A
Other languages
English (en)
Other versions
MX364956B (es
Inventor
Paul Patel
Douglas Matje
Ian Gibbons
Elizabeth A Holmes
Original Assignee
Theranos Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theranos Inc filed Critical Theranos Inc
Publication of MX2015007131A publication Critical patent/MX2015007131A/es
Publication of MX364956B publication Critical patent/MX364956B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/60Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving cholesterol
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/61Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving triglycerides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2326/00Chromogens for determinations of oxidoreductase enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2326/00Chromogens for determinations of oxidoreductase enzymes
    • C12Q2326/90Developer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2326/00Chromogens for determinations of oxidoreductase enzymes
    • C12Q2326/90Developer
    • C12Q2326/964-Amino-antipyrine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00Reactions characterised by treatment of reaction samples
    • C12Q2523/10Characterised by chemical treatment
    • C12Q2523/115Characterised by chemical treatment oxidising agents
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/902Oxidoreductases (1.)
    • G01N2333/904Oxidoreductases (1.) acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/902Oxidoreductases (1.)
    • G01N2333/908Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/918Carboxylic ester hydrolases (3.1.1)
    • G01N2333/92Triglyceride splitting, e.g. by means of lipase

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plasma & Fusion (AREA)

Abstract

Se proporcionan reactivos, ensayos, métodos, equipos, dispositivos y sistemas para la medición rápida de colesterol y sub-fracciones de colesterol de una muestra de sangre. Se pueden medir el colesterol total, lipoproteína de baja densidad-colesterol, y lipoproteína de alta densidad-colesterol en un ensayo individual usando mediciones cinéticas, bajo condiciones en las cuales se convierten a sub-especies de colesterol a un producto detectable a distintas velocidades. El producto detectable se mide en diferentes momentos después del inicio del ensayo. Se puede usar una lipasa, una colesterol-esterasa, una colesterol-oxidasa y una peroxidasa conjuntamente para producir el producto coloreado en cantidades directamente proporcionales a la cantidad de colesterol convertido. Los métodos para calcular los niveles de lipoproteína de muy baja densidad-colesterol al incluir además mediciones de triglicéridos se describen. Los ensayos se pueden realizar en una mezcla de reacción individual, permitiendo determinaciones más exactas y precisas de colesterol, incluyendo relaciones de sub-fracciones de colesterol a colesterol total, a menos costo, creo que se esperaría realizar varios ensayos diferentes en diferentes mezclas de reacción.
MX2015007131A 2012-12-10 2013-12-10 Ensayos rapidos de bajo volumen de muestra de colesterol y trigliceridos. MX364956B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261735424P 2012-12-10 2012-12-10
PCT/US2013/074211 WO2014093399A1 (en) 2012-12-10 2013-12-10 Rapid, low-sample-volume cholesterol and triglyceride assays

Publications (2)

Publication Number Publication Date
MX2015007131A true MX2015007131A (es) 2015-10-14
MX364956B MX364956B (es) 2019-05-15

Family

ID=50931352

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015007131A MX364956B (es) 2012-12-10 2013-12-10 Ensayos rapidos de bajo volumen de muestra de colesterol y trigliceridos.

Country Status (13)

Country Link
US (4) US9051599B2 (es)
EP (2) EP2929046B1 (es)
JP (4) JP2016505250A (es)
KR (1) KR20150094710A (es)
CN (2) CN104995310B (es)
AU (1) AU2013359422A1 (es)
CA (1) CA2891944A1 (es)
ES (1) ES2729794T3 (es)
HK (1) HK1216763A1 (es)
IL (1) IL239229A (es)
MX (1) MX364956B (es)
SG (1) SG11201504455PA (es)
WO (1) WO2014093399A1 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3138078C (en) 2007-10-02 2024-02-13 Labrador Diagnostics Llc Modular point-of-care devices and uses thereof
CN106290160A (zh) 2011-01-21 2017-01-04 提拉诺斯公司 样品使用最大化的系统和方法
US9632102B2 (en) 2011-09-25 2017-04-25 Theranos, Inc. Systems and methods for multi-purpose analysis
US8475739B2 (en) 2011-09-25 2013-07-02 Theranos, Inc. Systems and methods for fluid handling
US20140170735A1 (en) 2011-09-25 2014-06-19 Elizabeth A. Holmes Systems and methods for multi-analysis
US9268915B2 (en) 2011-09-25 2016-02-23 Theranos, Inc. Systems and methods for diagnosis or treatment
US9619627B2 (en) 2011-09-25 2017-04-11 Theranos, Inc. Systems and methods for collecting and transmitting assay results
US9664702B2 (en) 2011-09-25 2017-05-30 Theranos, Inc. Fluid handling apparatus and configurations
US9250229B2 (en) 2011-09-25 2016-02-02 Theranos, Inc. Systems and methods for multi-analysis
US10012664B2 (en) 2011-09-25 2018-07-03 Theranos Ip Company, Llc Systems and methods for fluid and component handling
US9810704B2 (en) 2013-02-18 2017-11-07 Theranos, Inc. Systems and methods for multi-analysis
US9051599B2 (en) 2012-12-10 2015-06-09 Theranos, Inc. Rapid, low-sample-volume cholesterol and triglyceride assays
KR20160053979A (ko) 2013-09-06 2016-05-13 테라노스, 인코포레이티드 전염성 질환의 검출을 위한 시스템 및 방법
MX2016002797A (es) 2013-09-06 2016-05-26 Theranos Inc Dispositivos, sistemas, metodos y equipos para recibir un hisopo.
CN104914141B (zh) * 2015-01-30 2017-10-17 南京工业大学 一种新型低密度脂蛋白胆固醇电化学免疫传感器的制备及应用
CN104865392B (zh) * 2015-05-02 2016-09-14 王贤俊 一种ldl-c定量检测方法
KR101882485B1 (ko) 2016-06-30 2018-07-27 강경찬 체내 간기능효소 및 지질 함유량 측정방법
CN106399460B (zh) * 2016-09-29 2020-03-17 中国医学科学院北京协和医院 用于测定甘油三酯的试剂盒和方法
CN106367471B (zh) * 2016-09-29 2021-12-03 中国医学科学院北京协和医院 用于测定总胆固醇的试剂盒和方法
CN106950095B (zh) * 2017-04-01 2020-01-10 合肥迪安医学检验所有限公司 一种减少脂血样本检测干扰的方法
CN108690869A (zh) * 2017-04-05 2018-10-23 广州市伊川生物科技有限公司 一种高密度脂蛋白胆固醇检测试剂盒及其检测方法
CN108949903B (zh) * 2017-05-17 2021-11-16 广州市伊川生物科技有限公司 一种甘油三酯测定试剂盒及其测定方法
US10684277B2 (en) * 2017-07-24 2020-06-16 Comsats Institute Of Information Technology Colorimetric filter paper assay for rapid monitoring of cholesterol level
AU2019207642A1 (en) * 2018-01-09 2020-07-02 Idexx Laboratories, Inc. Methods for measuring analyte and/or protein in biological samples
CN109580511A (zh) * 2018-12-06 2019-04-05 潍坊泽成生物技术有限公司 一种高密度脂蛋白胆固醇的检测方法及检测试剂盒
CN109799356A (zh) * 2018-12-28 2019-05-24 上海高踪医疗器械科技有限公司 一种测定高密度脂蛋白胆固醇的试剂盒及方法
LU101273B1 (en) * 2019-06-21 2020-12-28 Ecole Polytechnique Fed Lausanne Epfl Sensing platform
KR20220045198A (ko) 2019-08-08 2022-04-12 옵스에파 에스에이 에스트로겐-의존성 장애의 치료를 위한 gnrh 길항제
CN111829991A (zh) * 2020-08-04 2020-10-27 东北大学 基于β-CD的反射式光纤胆固醇传感器及其制备方法
CN113008807A (zh) * 2021-03-10 2021-06-22 谱天(天津)生物科技有限公司 一种测定极低密度脂蛋白亚组份成分分布的方法
WO2023049473A1 (en) * 2021-09-27 2023-03-30 Icahn School Of Medicine At Mount Sinai System and method to determine the concentration of lipoprotein (a) cholesterol
CN113897413A (zh) * 2021-10-12 2022-01-07 广州达安基因股份有限公司 一种体外诊断试剂防腐剂及其用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3208253A1 (de) * 1982-03-08 1983-09-15 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur spezifischen bestimmung des cholesterins der ldl-fraktion im serum
US4495293A (en) * 1983-02-24 1985-01-22 Abbott Laboratories Fluorometric assay
GB8531755D0 (en) 1985-12-24 1986-02-05 Genetics Int Inc Assay for cholestrol & derivatives
DE3636851A1 (de) * 1986-10-29 1988-05-11 Boehringer Mannheim Gmbh Verfahren und reagenz zur spezifischen bestimmung des cholesterins der hdl-fraktion
US5215886A (en) 1987-06-22 1993-06-01 Patel P Jivan HDL determination in whole blood
JP2600065B2 (ja) * 1994-03-08 1997-04-16 協和メデックス株式会社 高密度リポ蛋白中のコレステロールの定量法
US5814472A (en) * 1997-05-13 1998-09-29 Wako Pure Chemical Industries, Ltd. Measurement of LDL-cholesterol
EP1577398A4 (en) * 2002-12-13 2006-07-26 Denka Seiken Kk METHOD FOR THE MULTIPLE QUANTIFICATION OF CHOLESTEROL IN LIPOPROTEINS OF LOW DENSITY
JP4647927B2 (ja) * 2004-03-31 2011-03-09 デンカ生研株式会社 低密度リポ蛋白中コレステロールのマルチ定量法
JP5129572B2 (ja) 2005-09-30 2013-01-30 デンカ生研株式会社 生体試料中の2項目の測定対象物の同時分別定量方法
EP1975244A4 (en) 2006-01-20 2009-06-17 Jimro Co Ltd PROCESS FOR CHOLESTERIN MEASUREMENT IN REMAINING LIPOPROTEINS
CA3138078C (en) 2007-10-02 2024-02-13 Labrador Diagnostics Llc Modular point-of-care devices and uses thereof
JP4889670B2 (ja) 2008-03-26 2012-03-07 富士フイルム株式会社 溶血の影響を低減した体液成分測定用乾式分析素子
US8380541B1 (en) 2011-09-25 2013-02-19 Theranos, Inc. Systems and methods for collecting and transmitting assay results
EP2751575B1 (en) * 2011-11-11 2018-09-12 Axis-Shield AS Blood sample assay method
US9051599B2 (en) 2012-12-10 2015-06-09 Theranos, Inc. Rapid, low-sample-volume cholesterol and triglyceride assays

Also Published As

Publication number Publication date
JP2021006060A (ja) 2021-01-21
IL239229A (en) 2017-02-28
EP2929046A4 (en) 2016-06-29
CN104995310B (zh) 2020-07-28
KR20150094710A (ko) 2015-08-19
JP2016505250A (ja) 2016-02-25
US20160024554A1 (en) 2016-01-28
ES2729794T3 (es) 2019-11-06
JP2023015207A (ja) 2023-01-31
CN104995310A (zh) 2015-10-21
US10392650B2 (en) 2019-08-27
JP2019054811A (ja) 2019-04-11
US11268130B2 (en) 2022-03-08
EP2929046B1 (en) 2019-03-20
MX364956B (es) 2019-05-15
US20200063185A1 (en) 2020-02-27
CA2891944A1 (en) 2014-06-19
US20140170688A1 (en) 2014-06-19
WO2014093399A1 (en) 2014-06-19
US9546394B2 (en) 2017-01-17
IL239229A0 (en) 2015-07-30
AU2013359422A1 (en) 2015-06-04
EP2929046A1 (en) 2015-10-14
US20170175168A1 (en) 2017-06-22
US9051599B2 (en) 2015-06-09
HK1216763A1 (zh) 2016-12-02
CN111748605A (zh) 2020-10-09
EP3561068A1 (en) 2019-10-30
SG11201504455PA (en) 2015-07-30

Similar Documents

Publication Publication Date Title
MX2015007131A (es) Ensayos rapidos de bajo volumen de muestra de colesterol y trigliceridos.
BR112013033082A2 (pt) método para detectar a presença de bactérias produtoras de carbapenemase em uma amostra
MX2020004617A (es) Prediccion de riesgo de evento cardiovascular y usos del mismo.
WO2013068572A3 (en) Blood sample assay method
MX363201B (es) Procedimiento, matriz y uso para determinar la presencia de cancer pancreatico.
IN2014DN08135A (es)
BR112012011230A2 (pt) fatores de risco e previsão de infarto do miocárdio
EP2370599A1 (en) Method for determining copy number variations
EP3495799A3 (en) A method for measurement of a component in cells
WO2014186761A3 (en) Methods for determining responsiveness to an anti-cd47 agent
NZ720529A (en) Methods for measuring enzyme activity useful in determining cell viability in non-purified samples
JP2013063072A5 (es)
NZ610067A (en) Predicting progression to advanced age-related macular degeneration using a polygenic score
BR112013023409A2 (pt) método e kit de teste para determinar a concentração de nitrato
CA2874960C (en) Euglobulin-based method for determining the biological activity of defibrotide
WO2012011660A3 (ko) 시료 내장 마이크로 챔버 플레이트 및 분석용 마이크로 챔버 프레이트의 제조 방법, 분석용 마이크로 챔버 플레이트 및 시료 내장 마이크로 챔버 플레이트 제조 장치 셋
GB201019674D0 (en) Analysis of direct factor Xa Inhibitor
WO2011011535A3 (en) Methods and compositions for quantitative detection of nucleic acid sequences over an extended dynamic range
WO2009031506A1 (ja) 低密度リポタンパク質(ldl)コレステロール測定方法およびldlコレステロール測定用試験片
MX336940B (es) Uso de compuestos mejoradores de señal en deteccion de electroquimioluminiscencia.
WO2014052613A3 (en) Methods and compositions relating to next generation sequencing for genetic testing in alk related cancers
IN2014DN06516A (es)
WO2012145516A3 (en) Methods and kits for quantitative determination of total organic acid content in a coolant
WO2011148269A3 (en) Differentiation of species within the mycobacterium tuberculosis complex
WO2011008814A3 (en) Multiplexed measurement of exogenous and endogenous dna

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: THERANOS IP COMPANY, LLC

FG Grant or registration